The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series.

[1]  O. Olopade,et al.  BREAST CANCER GENETICS: Implications for Clinical Practice , 2000 .

[2]  M. Stratton,et al.  The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  K. Heimdal,et al.  Efficacy of Early Diagnosis and Treatment in Women with a Family History of Breast Cancer , 2002, Disease Markers.

[4]  M. Beckmann,et al.  Utilisation of Prophylactic Mastectomy in 10 European Centres , 2002, Disease markers.

[5]  J. Chang-Claude,et al.  Guidelines for Follow-Up of Women at High Risk for Inherited Breast Cancer: Consensus Statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer , 2002, Disease markers.

[6]  K. Heimdal,et al.  BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations , 2002, Disease markers.

[7]  P. Oefner,et al.  Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. , 1999, Genomics.

[8]  K. Heimdal,et al.  Prospectively detected cancer in familial breast/ovarian cancer screening , 1999, Acta obstetricia et gynecologica Scandinavica.

[9]  K. Heimdal,et al.  Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer. , 1999, American journal of human genetics.

[10]  D. Berry,et al.  Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. , 1998, Journal of the National Cancer Institute.

[11]  J. Struewing,et al.  Population-based study of risk of breast cancer in carriers of BRCA2 mutation , 1998, The Lancet.

[12]  M. Stratton,et al.  Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. , 1998, Journal of the National Cancer Institute.

[13]  T. Aas,et al.  Prospective findings in breast cancer kindreds: annual incidence rates according to age, stage at diagnosis, mean sojourn time, and incidence rates for contralateral cancer , 1998 .

[14]  D. Berry,et al.  Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.

[15]  Hanlee P. Ji,et al.  Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. , 1997, American journal of human genetics.

[16]  Å. Borg,et al.  Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. , 1997, American journal of human genetics.

[17]  Å. Borg,et al.  Tumour biological features of BRCA1-induced breast and ovarian cancer. , 1997, European journal of cancer.

[18]  D. Birnbaum,et al.  Histoprognostic Grade in Hereditary Breast Cancer: Is Inheritance Linked to BRCA1 a Bad Prognostic Factor? , 1996 .

[19]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.